SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-003548
Filing Date
2024-06-20
Accepted
2024-06-20 16:05:48
Documents
14
Period of Report
2024-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062024.htm   iXBRL 8-K 32210
  Complete submission text file 0001171843-24-003548.txt   251499

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20240618.xsd EX-101.SCH 3254
3 XBRL DEFINITION FILE apto-20240618_def.xml EX-101.DEF 26186
4 XBRL LABEL FILE apto-20240618_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE apto-20240618_pre.xml EX-101.PRE 24844
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062024_htm.xml XML 5358
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 241056214
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)